drugset / Trial / NCT02989129

Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients

NCT02989129

Phase 0 Withdrawn M.D. Anderson Cancer Center
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to learn about the effectiveness of quercetin in treating and preventing CINP. Researchers also want to learn if quercetin has an effect on participant's quality of life.

Timeline

Start
2018-04
Primary completion
2020-04
Completion
2020-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Quercetin Small molecule 500 mg Oral